Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
New York University School of Medicine Identifier:
First received: April 6, 2000
Last updated: November 8, 2012
Last verified: November 2000
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2000 (Final data collection date for primary outcome measure)